Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1964 Dec;27(6):485–492. doi: 10.1136/jnnp.27.6.485

Immunological disturbances in myasthenia gravis with a report of Hashimoto's disease developing after thymectomy1

John A Simpson 1,2
PMCID: PMC495787  PMID: 14249387

Full text

PDF
485

Images in this article

487Image
on p.487
489Image
on p.489
489Image
on p.489
490Image
on p.490

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALARCON SEGOVIA D., GALBRAITH R. F., MALDONADO J. E., HOWARD F. M., Jr SYSTEMIC LUPUS ERYTHEMATOSUS FOLLOWING THYMECTOMY FOR MYSTHENIA GRAVIS. REPORT OF TWO CASES. Lancet. 1963 Sep 28;2(7309):662–665. doi: 10.1016/s0140-6736(63)90456-2. [DOI] [PubMed] [Google Scholar]
  2. ALEXANDER W. R., BREMNER J. M., DUTHIE J. J. Incidence of the anti-nuclear factor in human sera. Ann Rheum Dis. 1960 Dec;19:338–350. doi: 10.1136/ard.19.4.338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. ARAPAKIS G., BOCK O. A., WILLIAMS D. L., WITTS L. J. Diabetes mellitus and pernicious anaemia. Br Med J. 1963 Jan 19;1(5324):159–161. doi: 10.1136/bmj.1.5324.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BECKETT A. G., MATTHEWS D. M. Vitamin B12 in diabetes mellitus. Clin Sci. 1962 Oct;23:361–370. [PubMed] [Google Scholar]
  5. BURNET F. M. The immunological significance of the thymus: an extension of the clonal selection theory of immunity. Australas Ann Med. 1962 May;11:79–91. doi: 10.1111/imj.1962.11.2.79. [DOI] [PubMed] [Google Scholar]
  6. BURWELL R. G. The role of lymphoid tissue in morphostasis. Lancet. 1963 Jul 13;2(7298):69–74. doi: 10.1016/s0140-6736(63)90067-9. [DOI] [PubMed] [Google Scholar]
  7. DALY J. J., JACKSON E. CASE OF HASHIMOTO'S DISEASE WITH MYASTHENIA GRAVIS. Br Med J. 1964 Mar 21;1(5385):748–748. doi: 10.1136/bmj.1.5385.748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. FELTKAMP T. E., van der GELD, KRUYFF K., OOSTERHUIS H. J. Antinuclear factor in myasthenia gravis. Lancet. 1963 Mar 23;1(7282):667–667. doi: 10.1016/s0140-6736(63)91302-3. [DOI] [PubMed] [Google Scholar]
  9. FORBES G. B. Autohaemagglutination and Raynaud's phenomenon. Br Med J. 1947 May 3;1(4504):598–600. doi: 10.1136/bmj.1.4504.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Feltkamp T. E., van der Geld H., Oosterhuis H. J. Studies on sera from cases of myasthenia gravis, using the fluorescent antibody technique. Vox Sang. 1963 May-Jun;8(3):317–327. [PubMed] [Google Scholar]
  11. GREEN R. A., BOOTH C. B. The development of myasthenia gravis after removal of thymoma. Am J Med. 1958 Aug;25(2):293–302. doi: 10.1016/0002-9343(58)90035-4. [DOI] [PubMed] [Google Scholar]
  12. HARVEY A. M., SHULMAN L. E., TUMULTY P. A., CONLEY C. L., SCHOENRICH E. H. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 1954 Dec;33(4):291–437. [PubMed] [Google Scholar]
  13. HOLBOROW E. J., ASHERSON G. L., JOHNSON G. D., BARNES R. D., CARMICHAEL D. S. Antinuclear factor and other antibodies in blood and liver diseases. Br Med J. 1963 Mar 9;1(5331):656–658. doi: 10.1136/bmj.1.5331.656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. MARSHALL A. H., WHITE R. G. Experimental thymic lesions resembling those of myasthenia gravis. Lancet. 1961 May 13;1(7185):1030–1031. doi: 10.1016/s0140-6736(61)91834-7. [DOI] [PubMed] [Google Scholar]
  15. NASTUK W. L., PLESCIA O. J., OSSERMAN K. E. Changes in serum complement activity in patients with myasthenia gravis. Proc Soc Exp Biol Med. 1960 Oct;105:177–184. doi: 10.3181/00379727-105-26050. [DOI] [PubMed] [Google Scholar]
  16. NASTUK W. L., PLESCIA O. J., OSSERMAN K. E. Changes in serum complement activity in patients with myasthenia gravis. Proc Soc Exp Biol Med. 1960 Oct;105:177–184. doi: 10.3181/00379727-105-26050. [DOI] [PubMed] [Google Scholar]
  17. NASTUK W. L., STRAUSS A. J., OSSERMAN K. E. Search for a neuromuscular blocking agent in the blood of patients with myasthenia gravis. Am J Med. 1959 Mar;26(3):394–409. doi: 10.1016/0002-9343(59)90248-7. [DOI] [PubMed] [Google Scholar]
  18. PARTRIDGE R. E., DUTHIE J. J. Incidence of macrocytic anaemia in rheumatoid arthritis. Br Med J. 1963 Jan 12;1(5323):89–91. doi: 10.1136/bmj.1.5323.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. ROWLAND L. P., HOEFER P. F., ARANOW H., Jr, MERRITT H. H. Fatalities in myasthenia gravis; a review of 39 cases with 26 autopsies. Neurology. 1956 May;6(5):307–326. doi: 10.1212/wnl.6.5.307. [DOI] [PubMed] [Google Scholar]
  21. SCHWARTZ M. Intrinsic factor antibody in serum from patients with pernicious anaemia. Lancet. 1960 Dec 10;2(7163):1263–1267. doi: 10.1016/s0140-6736(60)92461-2. [DOI] [PubMed] [Google Scholar]
  22. SIMPSON J. A. An evaluation of thymectomy in myasthenia gravis. Brain. 1958 Mar;81(1):112–144. doi: 10.1093/brain/81.1.112. [DOI] [PubMed] [Google Scholar]
  23. TAYLOR K. B., ROITT I. M., DONIACH D., COUCHMAN K. G., SHAPLAND C. Autoimmune phenomena in pernicious anaemia: gastric antibodies. Br Med J. 1962 Nov 24;2(5316):1347–1352. doi: 10.1136/bmj.2.5316.1347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. VAN DER GELD H., FELTKAMP T. E., VAN LOGHEM J., OOSTERHUIS H. J., BIEMOND A. MULTIPLE ANTIBODY PRODUCTION IN MYASTHENIA GRAVIS. Lancet. 1963 Aug 24;2(7304):373–375. doi: 10.1016/s0140-6736(63)93055-1. [DOI] [PubMed] [Google Scholar]
  25. WEISS P. Perspectives in the field of morphogenesis. Q Rev Biol. 1950 Jun;25(2):177–198. doi: 10.1086/397540. [DOI] [PubMed] [Google Scholar]
  26. WHITE R. G., MARSHALL A. H. The autoimmune response in myasthenia gravis. Lancet. 1962 Jul 21;2(7247):120–123. doi: 10.1016/s0140-6736(62)90005-3. [DOI] [PubMed] [Google Scholar]
  27. van der GELD, OOSTERHUIS H. J. Muscle and thymus antibodies in myasthenia gravis. Vox Sang. 1963 Mar-Apr;8:196–204. doi: 10.1111/j.1423-0410.1963.tb03293.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES